Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564043 · ClinicalTrials.gov registry record · NA
Internet Walking Program and Pedometer in Chronic Obstructive Pulmonary Disease
A NA study, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01564043: Completed NA study, sponsored by VA Boston Healthcare System.
NCT01564043 is a NA study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01564043, a NA study, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Higher levels of physical activity are associated with better functional status, fewer hospital admissions, and lower mortality. The investigators studied the feasibility and safety of a novel program that combines a pedometer with a website to increase walking. This is a pilot study.
Interventions
- BEHAVIORAL website and pedometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-11 |
| Phase | NA |
What the finished NCT01564043 record still lists
NCT01564043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which website and pedometer is the first listed.
NCT01564043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01564043 about?
NCT01564043 is a clinical study titled "Internet Walking Program and Pedometer in Chronic Obstructive Pulmonary Disease". Higher levels of physical activity are associated with better functional status, fewer hospital admissions, and lower mortality. The investigators studied the feasibility and safety of a novel program that combines a pedometer with a website to increase walking. This is a pilot study.
What is the current status of trial NCT01564043?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-02. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01564043?
The interventions under investigation include: website and pedometer (BEHAVIORAL).
Who is sponsoring clinical trial NCT01564043?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01564043's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia